Merck
CN
HomeServicesBioReliance® Contract Testing ServicesViral Clearance Testing

Viral Clearance Testing

Viral Clearance Testing

Our viral clearance studies are designed and executed by experts in regulatory requirements, downstream processing, and virology. Having performed more than 17,300 viral clearance studies in our U.S., UK, China, and Singapore facilities, you can trust in us to minimize risk as you bring your product to market.

We offer three different regulatory-accepted service packages:

Learn more

Standard Clearance

Standard Viral Clearance Service lets you book study time in our state-of-the-art suites. Working closely with our highly experienced team, you’ll maintain full control and responsibility for running the viral clearance protocol, relying on us to provide the virus spike and perform all necessary titrations.

Hybrid Clearance

The Hybrid approach balances our Standard and Provise™ Service packages, with our expert team working in partnership with you to deliver a robust and reproducible viral clearance protocol.

Provise™ Clearance

Our Provise™ Clearance Service lets you focus on your core work while our experts take full responsibility for technical transfer and performance of your viral clearance protocol, along with a detailed report.

Whichever service model you choose, we perform IND- and BLA-enabling studies to meet global regulatory requirements for biologics:

  • Monoclonal antibodies
  • Recombinant proteins
  • Novel and biosimilar products
  • Vaccines
  • Gene therapy vectors - AAV

The outcome is confirmation that your viral clearance methodology supports your regulatory filing and manufacturing process.

BioPure™ virus stocks

We use BioPure™ virus to ensure high viral titers and low levels of potential contaminants, translating to outstanding performance for all downstream process studies. BioPure™ virus stocks are produced from fully-characterized virus stocks and are used to evaluate the reduction of virus.

BioPure™ Gold virus is used for nanofiltration steps for additional sensitivity, as it’s been subjected to additional purification to produce the cleanest and most aggregate-free material.

Your viral clearance partners will discuss the use of virus stocks in your specific studies.

Contact Us Today to Learn More or Request a Proposal

Related Resources

Flyer: BioReliance® Standard Viral Clearance Services
Infographic: BioReliance® Viral Clearance Services
Application Note: Designing Successful Viral Clearance Studies
Flyer: Roadmap to success - Provise™ Clearance Services

Related Applications
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Gene Therapy Manufacturing
Growing use of gene therapies is driving rapid innovation in an evolving global market. Manufacturers bringing new gene therapies to life face complex challenges, requiring an experienced partner capable of integrating vector manufacturing, testing, safety, process development, and regulatory compliance.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Related Product Categories
Filtration
High quality, consistent, and reliable filtration products for bioprocessing, laboratory filtration, pharma QC, and testing lab applications.
Chromatography & Spectroscopy Reagents
Explore our selection of high-quality analytical reagents for wet chemistry, chromatography, spectroscopy, analytical, titration, water quality control, and electrochemistry.
Related Services
Single-Use and Filter Validation Services
Accelerate and simplify your path to market by using our BioReliance® Validation Services to select, test, and validate your filters, assemblies, and single-use systems for drug manufacturing and processing.
Bulk Harvest Release Testing
Whether you’re preparing for first-in-human clinical trials or scaling up for global distribution of a life-changing therapeutic biologic, our cGMP-compliant bulk harvest release testing services protect your investment at every step.
Final Product Release Testing
With all biologics released into global pharmaceutical markets requiring GMP testing of final product, we offer a wide range of assays and lot release testing services to help you demonstrate compliance with regulatory guidelines.
Slide 1 of 0
    Sign In To Continue

    To continue reading please sign in or create an account.

    Don't Have An Account?